Literature DB >> 9771764

Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia.

L J Garey1, W Y Ong, T S Patel, M Kanani, A Davis, A M Mortimer, T R Barnes, S R Hirsch.   

Abstract

OBJECTIVE: A pilot study of the density of dendritic spines on pyramidal neurons in layer III of human temporal and frontal cerebral neocortex in schizophrenia.
METHODS: Postmortem material from a group of eight prospectively diagnosed schizophrenic patients, five archive schizophrenic patients, 11 non-schizophrenic controls, and one patient with schizophrenia-like psychosis, thought to be due to substance misuse, was impregnated with a rapid Golgi method. Spines were counted on the dendrites of pyramidal neurons in temporal and frontal association areas, of which the soma was in layer III (which take part in corticocortical connectivity) and which met strict criteria for impregnation quality. Altogether 25 blocks were studied in the schizophrenic group and 21 in the controls. If more than one block was examined from a single area, the counts for that area were averaged. All measurements were made blind: diagnoses were only disclosed by a third party after measurements were completed. Possible confounding affects of coexisting Alzheimer's disease were taken into account, as were the effects of age at death and postmortem interval.
RESULTS: There was a significant (p<0.001) reduction in the numerical density of spines in schizophrenia (276/mm in control temporal cortex and 112/mm in schizophrenic patients, and 299 and 101 respectively in the frontal cortex). An analysis of variance, taking out effects of age at death and postmortem interval, which might have explained the low spine density for some of the schizophrenic patients, did not affect the significance of the results.
CONCLUSION: The results support the concept of there being a defect in the fine structure of dendrites of pyramidal neurons, involving loss of spines, in schizophrenia and may help to explain the loss of cortical volume without loss of neurons in this condition, although the effect of neuroleptic drugs cannot be ruled out.

Entities:  

Mesh:

Year:  1998        PMID: 9771764      PMCID: PMC2170311          DOI: 10.1136/jnnp.65.4.446

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  36 in total

1.  A light and electron microscopic study of GluR4-positive cells in human cerebral cortex.

Authors:  W Y Ong; L J Garey
Journal:  Neurosci Lett       Date:  1996-05-31       Impact factor: 3.046

2.  Widespread cerebral gray matter volume deficits in schizophrenia.

Authors:  R B Zipursky; K O Lim; E V Sullivan; B W Brown; A Pfefferbaum
Journal:  Arch Gen Psychiatry       Date:  1992-03

3.  Patterns of cerebral blood flow in schizophrenia.

Authors:  P F Liddle; K J Friston; C D Frith; S R Hirsch; T Jones; R S Frackowiak
Journal:  Br J Psychiatry       Date:  1992-02       Impact factor: 9.319

4.  Alzheimer-type neuropathology in elderly schizophrenia patients.

Authors:  I Prohovnik; A J Dwork; M A Kaufman; N Willson
Journal:  Schizophr Bull       Date:  1993       Impact factor: 9.306

5.  Significant reductions in synapsin but not synaptophysin specific activity in the brains of some schizophrenics.

Authors:  M D Browning; E M Dudek; J L Rapier; S Leonard; R Freedman
Journal:  Biol Psychiatry       Date:  1993-10-15       Impact factor: 13.382

Review 6.  Reduction of cortical volume in schizophrenia on magnetic resonance imaging.

Authors:  I Harvey; M A Ron; G Du Boulay; D Wicks; S W Lewis; R M Murray
Journal:  Psychol Med       Date:  1993-08       Impact factor: 7.723

7.  Ultrastructural features of biopsied temporopolar cortex (area 38) in a case of schizophrenia.

Authors:  W Y Ong; L J Garey
Journal:  Schizophr Res       Date:  1993-06       Impact factor: 4.939

8.  The NMDA receptor subunits NR2A and NR2B show histological and ultrastructural localization patterns similar to those of NR1.

Authors:  R S Petralia; Y X Wang; R J Wenthold
Journal:  J Neurosci       Date:  1994-10       Impact factor: 6.167

Review 9.  Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited.

Authors:  M S Keshavan; S Anderson; J W Pettegrew
Journal:  J Psychiatr Res       Date:  1994 May-Jun       Impact factor: 4.791

10.  Light and electron microscopic characterization of dopamine-immunoreactive axons in human cerebral cortex.

Authors:  J F Smiley; S M Williams; K Szigeti; P S Goldman-Rakic
Journal:  J Comp Neurol       Date:  1992-07-15       Impact factor: 3.215

View more
  232 in total

1.  Chronic administration of the neurotrophic agent cerebrolysin ameliorates the behavioral and morphological changes induced by neonatal ventral hippocampus lesion in a rat model of schizophrenia.

Authors:  Rubén Antonio Vázquez-Roque; Brenda Ramos; Carolina Tecuatl; Ismael Juárez; Anthony Adame; Fidel de la Cruz; Sergio Zamudio; Raúl Mena; Edward Rockenstein; Eliezer Masliah; Gonzalo Flores
Journal:  J Neurosci Res       Date:  2011-09-19       Impact factor: 4.164

Review 2.  GABAergic interneuron origin of schizophrenia pathophysiology.

Authors:  Kazu Nakazawa; Veronika Zsiros; Zhihong Jiang; Kazuhito Nakao; Stefan Kolata; Shuqin Zhang; Juan E Belforte
Journal:  Neuropharmacology       Date:  2011-01-26       Impact factor: 5.250

Review 3.  Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment.

Authors:  Christine Konradi; Stephan Heckers
Journal:  Pharmacol Ther       Date:  2003-02       Impact factor: 12.310

4.  The actin-binding domain of spinophilin is necessary and sufficient for targeting to dendritic spines.

Authors:  Stacie D Grossman; Linda C Hsieh-Wilson; Patrick B Allen; Angus C Nairn; Paul Greengard
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

Review 5.  New spines, new memories.

Authors:  Benedetta Leuner; Tracey J Shors
Journal:  Mol Neurobiol       Date:  2004-04       Impact factor: 5.590

Review 6.  Postmortem investigations of the pathophysiology of schizophrenia: the role of susceptibility genes.

Authors:  William R Perlman; Cynthia Shannon Weickert; Mayada Akil; Joel E Kleinman
Journal:  J Psychiatry Neurosci       Date:  2004-07       Impact factor: 6.186

Review 7.  Defects in Bioenergetic Coupling in Schizophrenia.

Authors:  Courtney R Sullivan; Sinead M O'Donovan; Robert E McCullumsmith; Amy Ramsey
Journal:  Biol Psychiatry       Date:  2017-10-24       Impact factor: 13.382

Review 8.  Remodeling of axo-spinous synapses in the pathophysiology and treatment of depression.

Authors:  P Licznerski; R S Duman
Journal:  Neuroscience       Date:  2012-10-02       Impact factor: 3.590

9.  DNA-methyltransferase 1 mRNA is selectively overexpressed in telencephalic GABAergic interneurons of schizophrenia brains.

Authors:  M Veldic; H J Caruncho; W S Liu; J Davis; R Satta; D R Grayson; A Guidotti; E Costa
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-18       Impact factor: 11.205

10.  Effects of davunetide on N-acetylaspartate and choline in dorsolateral prefrontal cortex in patients with schizophrenia.

Authors:  L Fredrik Jarskog; Zhengchao Dong; Alayar Kangarlu; Tiziano Colibazzi; Ragy R Girgis; Lawrence S Kegeles; Deanna M Barch; Robert W Buchanan; John G Csernansky; Donald C Goff; Michael P Harms; Daniel C Javitt; Richard Se Keefe; Joseph P McEvoy; Robert P McMahon; Stephen R Marder; Bradley S Peterson; Jeffrey A Lieberman
Journal:  Neuropsychopharmacology       Date:  2013-01-16       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.